Sign in
OSCE stations › Research consent for an investigational drug when you have ties to the sponsor
Full access · Communication · Ethical issues: DNR, capacity, surrogates, refusal · 12 min

Research consent for an investigational drug when you have ties to the sponsor

Full access

Unlock this station

Full access opens all 15 mock oral exams, all 39 OSCE stations and the timed seven-station circuit. One payment of $99 for 90 days, no subscription.

Try a free station of each type · What’s included

Door card

Mr. Harold Okafor is a 68-year-old retired school principal, 90 kg, scheduled tomorrow for a right total knee replacement under spinal anesthesia with an adductor canal block. A research coordinator has given him the consent form for an IRB-approved, randomized, double-blind trial. The surgeon will inject either an investigational extended-release local anesthetic or standard bupivacaine around the knee; everyone also gets the usual block and pain medicines.

You are the site's principal investigator. The sponsor pays the department a set amount for each enrolled patient to cover research staff costs, and in the year before the study opened it paid you speaking fees, which stopped when you became investigator; the hospital's research office has both on file. Mr. Okafor asked to talk with you before deciding.

Your task: answer his questions about the study and confirm his decision.